Over three million people living with HIV/AIDS in the developing world receive antiretroviral therapy (ART). However, the medicines and diagnostic tools available are inadequate to respond fully to their needs. In addition, seven million people are in need of treatment and are still waiting for access.
The number of patients on treatment has risen dramatically over the last few years. At the end of August 2010, more than 200,000 patients were on ARV treatment in Mozambique, of whom more than 33,000 were being treated with the assistance of MSF.
While gains made in the fight against HIV/AIDS in the past decade are encouraging, countries most affected by the pandemic continue to struggle to place enough people on treatment and implement the best science and strategies to fight the disease.